Le Gautier

May 23, 2023 | trialsjournal.biomedcentral.com | Mary Lou |van Bruggen |Diabetes Victoria |Le Gautier

DesignThis study uses a hybrid type I effectiveness-implementation trial design [26] to test the effectiveness of LISTEN in a two-arm pragmatic, individual-level randomised controlled trial (RCT). We will simultaneously gather information on any barriers to, and facilitators of, implementation [26]. LISTEN (intervention) will be compared to usual care (comparison group), in terms of its impact on diabetes distress at 8 weeks (T1) and 6 months (T2) post-randomisation.